• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氧化钛纳米复合涂层与产碳青霉烯酶肺炎克雷伯菌生物膜的灭活——机遇与挑战

TiO Nanocomposite Coatings and Inactivation of Carbapenemase-Producing Klebsiella Pneumoniae Biofilm-Opportunities and Challenges.

作者信息

Bereanu Alina-Simona, Vintilă Bogdan Ioan, Bereanu Rareș, Codru Ioana Roxana, Hașegan Adrian, Olteanu Ciprian, Săceleanu Vicențiu, Sava Mihai

机构信息

Faculty of Medicine, Lucian Blaga University of Sibiu, Lucian Blaga Street 2A, 550169 Sibiu, Romania.

County Clinical Emergency Hospital, Bld. Corneliu Coposu nr. 2-4, 550245 Sibiu, Romania.

出版信息

Microorganisms. 2024 Mar 28;12(4):684. doi: 10.3390/microorganisms12040684.

DOI:10.3390/microorganisms12040684
PMID:38674628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11051735/
Abstract

The worldwide increase of multidrug-resistant Gram-negative bacteria is a global threat. The emergence and global spread of carbapenemase- (KPC-) producing represent a particular concern. This pathogen has increased resistance and abilities to persist in human reservoirs, in hospital environments, on medical devices, and to generate biofilms. Mortality related to this microorganism is high among immunosuppressed oncological patients and those with multiple hospitalizations and an extended stay in intensive care. There is a severe threat posed by the ability of biofilms to grow and resist antibiotics. Various nanotechnology-based strategies have been studied and developed to prevent and combat serious health problems caused by biofilm infections. The aim of this review was to evaluate the implications of nanotechnology in eradicating biofilms with KPC-producing , one of the bacteria most frequently associated with nosocomial infections in intensive care units, including in our department, and to highlight studies presenting the potential applicability of TiO nanocomposite materials in hospital practice. We also described the frequency of the presence of bacterial biofilms on medical surfaces, devices, and equipment. TiO nanocomposite coatings are one of the best long-term options for antimicrobial efficacy due to their biocompatibility, stability, corrosion resistance, and low cost; they find their applicability in hospital practice due to their critical antimicrobial role for surfaces and orthopedic and dental implants. The International Agency for Research on Cancer has recently classified titanium dioxide nanoparticles (TiO NPs) as possibly carcinogenic. Currently, there is an interest in the ecological, non-toxic synthesis of TiO nanoparticles via biological methods. Biogenic, non-toxic nanoparticles have remarkable properties due to their biocompatibility, stability, and size. Few studies have mentioned the use of nanoparticle-coated surfaces as antibiofilm agents. A literature review was performed to identify publications related to KPC-producing biofilms and antimicrobial TiO photocatalytic nanocomposite coatings. There are few reviews on the antibacterial and antibiofilm applications of TiO photocatalytic nanocomposite coatings. TiO nanoparticles demonstrated marked antibiofilm activity, but being nano in size, these nanoparticles can penetrate cell membranes and may initiate cellular toxicity and genotoxicity. Biogenic TiO nanoparticles obtained via green, ecological technology have less applicability but are actively investigated.

摘要

全球范围内多重耐药革兰氏阴性菌的增加是一个全球性威胁。产碳青霉烯酶(KPC)细菌的出现和全球传播尤其令人担忧。这种病原体在人类宿主、医院环境、医疗设备中持续存在的耐药性和能力增强,并且能够形成生物膜。在免疫抑制的肿瘤患者以及多次住院并长期入住重症监护病房的患者中,与这种微生物相关的死亡率很高。生物膜生长和对抗生素耐药的能力构成了严重威胁。已经研究和开发了各种基于纳米技术的策略来预防和对抗由生物膜感染引起的严重健康问题。本综述的目的是评估纳米技术在根除产KPC细菌生物膜方面的意义,产KPC细菌是重症监护病房(包括我们科室)最常与医院感染相关的细菌之一,并强调展示TiO纳米复合材料在医院实践中潜在适用性的研究。我们还描述了细菌生物膜在医疗表面、设备和器材上存在的频率。TiO纳米复合涂层由于其生物相容性、稳定性、耐腐蚀性和低成本,是抗菌效果最佳的长期选择之一;由于它们对表面以及骨科和牙科植入物具有关键的抗菌作用,因此在医院实践中得到应用。国际癌症研究机构最近将二氧化钛纳米颗粒(TiO NPs)归类为可能致癌物质。目前,人们对通过生物方法进行生态、无毒的TiO纳米颗粒合成感兴趣。生物源无毒纳米颗粒由于其生物相容性、稳定性和尺寸而具有显著特性。很少有研究提及使用纳米颗粒涂层表面作为抗生物膜剂。进行了文献综述以确定与产KPC细菌生物膜和抗菌TiO光催化纳米复合涂层相关的出版物。关于TiO光催化纳米复合涂层的抗菌和抗生物膜应用的综述很少。TiO纳米颗粒表现出显著的抗生物膜活性,但由于其纳米尺寸,这些纳米颗粒可以穿透细胞膜并可能引发细胞毒性和基因毒性。通过绿色生态技术获得的生物源TiO纳米颗粒适用性较小,但正在积极研究中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/22d3fb6924c2/microorganisms-12-00684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/e014d546b722/microorganisms-12-00684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/84e731d30d2a/microorganisms-12-00684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/22d3fb6924c2/microorganisms-12-00684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/e014d546b722/microorganisms-12-00684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/84e731d30d2a/microorganisms-12-00684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/11051735/22d3fb6924c2/microorganisms-12-00684-g003.jpg

相似文献

1
TiO Nanocomposite Coatings and Inactivation of Carbapenemase-Producing Klebsiella Pneumoniae Biofilm-Opportunities and Challenges.二氧化钛纳米复合涂层与产碳青霉烯酶肺炎克雷伯菌生物膜的灭活——机遇与挑战
Microorganisms. 2024 Mar 28;12(4):684. doi: 10.3390/microorganisms12040684.
2
Antibiotic resistance and virulence characteristics of four carbapenem-resistant Klebsiella pneumoniae strains coharbouring bla and bla based on whole genome sequences from a tertiary general teaching hospital in central China between 2019 and 2021.2019 年至 2021 年间,中国中部一家三级综合性教学医院基于全基因组序列,发现 4 株同时携带 bla 和 bla 的碳青霉烯类耐药肺炎克雷伯菌的耐药性和毒力特征。
Microb Pathog. 2023 Feb;175:105969. doi: 10.1016/j.micpath.2023.105969. Epub 2023 Jan 4.
3
Antibacterial and antibiofilm efficacy of Ag NPs, Ni NPs and AlO NPs singly and in combination against multidrug-resistant Klebsiella pneumoniae isolates.Ag NPs、Ni NPs 和 AlO NPs 单独及联合应用对抗多重耐药肺炎克雷伯菌的抗菌和抗生物膜效果。
J Trace Elem Med Biol. 2021 Dec;68:126840. doi: 10.1016/j.jtemb.2021.126840. Epub 2021 Aug 14.
4
Evaluation of the Ability to Form Biofilms in KPC-Producing and ESBL-Producing Isolated from Clinical Samples.从临床样本中分离出的产KPC和产ESBL菌株形成生物膜能力的评估。
Antibiotics (Basel). 2023 Jul 2;12(7):1143. doi: 10.3390/antibiotics12071143.
5
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.在由产肺炎克雷伯菌碳青霉烯酶(KPC)的肺炎克雷伯菌引起的多克隆暴发中,解读对新型碳青霉烯类β-内酰胺酶抑制剂联合制剂的可变耐药性,该肺炎克雷伯菌对头孢他啶/阿维巴坦耐药。
Clin Microbiol Infect. 2023 Apr;29(4):537.e1-537.e8. doi: 10.1016/j.cmi.2022.11.011. Epub 2022 Nov 19.
6
In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing .头孢他啶-阿维巴坦对产碳青霉烯酶的. 的体外和体内杀菌活性。
Antimicrob Resist Infect Control. 2018 Nov 21;7:142. doi: 10.1186/s13756-018-0435-9. eCollection 2018.
7
Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.抗生物膜肽可提高产碳青霉烯酶肺炎克雷伯菌临床分离株对β-内酰胺类抗生素的敏感性。
Antimicrob Agents Chemother. 2015 Jul;59(7):3906-12. doi: 10.1128/AAC.00092-15. Epub 2015 Apr 20.
8
Phenotypic and molecular evaluation of biofilm formation in carbapenemase (KPC) isolates obtained from a hospital of Pelotas, RS, Brazil.巴西佩洛塔斯市一家医院分离的产碳青霉烯酶(KPC)菌株的生物膜形成的表型和分子评估。
J Med Microbiol. 2021 Nov;70(11). doi: 10.1099/jmm.0.001451.
9
Correlation between biofilm formation and carbapenem resistance among clinical isolates of ..临床分离株中生物膜形成与碳青霉烯类耐药性之间的相关性
Ethiop J Health Sci. 2019 Nov;29(6):745-750. doi: 10.4314/ejhs.v29i6.11.
10
Clinical and Molecular Description of a High-Copy IncQ1 KPC-2 Plasmid Harbored by the International ST15 Klebsiella pneumoniae Clone.国际ST15肺炎克雷伯菌克隆携带的高拷贝IncQ1型KPC-2质粒的临床与分子特征描述
mSphere. 2020 Oct 7;5(5):e00756-20. doi: 10.1128/mSphere.00756-20.

引用本文的文献

1
Lessons from Four Years (2021-2024) of Resistance Surveillance Epidemiological Trends in a Romanian Intensive Care Unit.罗马尼亚重症监护病房四年(2021 - 2024年)耐药监测流行病学趋势的经验教训
Antibiotics (Basel). 2025 Aug 12;14(8):825. doi: 10.3390/antibiotics14080825.
2
Antimicrobial Resistance Patterns and Biofilm Analysis via Sonication in Intensive Care Unit Patients at a County Emergency Hospital in Romania.罗马尼亚某县急救医院重症监护病房患者抗菌药物耐药模式及超声处理后的生物膜分析
Pharmaceuticals (Basel). 2025 Jan 25;18(2):161. doi: 10.3390/ph18020161.
3
Optimizing Diagnosis and Management of Ventilator-Associated Pneumonia: A Systematic Evaluation of Biofilm Detection Methods and Bacterial Colonization on Endotracheal Tubes.

本文引用的文献

1
Investigating the effects of zinc oxide and titanium dioxide nanoparticles on the formation of biofilm and persister cells in Klebsiella pneumoniae.研究氧化锌和二氧化钛纳米颗粒对肺炎克雷伯菌生物膜和持留菌形成的影响。
J Basic Microbiol. 2024 May;64(5):e2300454. doi: 10.1002/jobm.202300454. Epub 2023 Dec 20.
2
Evaluation of chitosan-Ag/TiO nanocomposite for the enhancement of shelf life of chili and banana fruits.壳聚糖-银/二氧化钛纳米复合材料对延长辣椒和香蕉果实货架期的评估
Heliyon. 2023 Oct 28;9(11):e21752. doi: 10.1016/j.heliyon.2023.e21752. eCollection 2023 Nov.
3
Within-Host Resistance and Virulence Evolution of a Hypervirulent Carbapenem-Resistant ST11 Under Antibiotic Pressure.
优化呼吸机相关性肺炎的诊断与管理:气管内导管生物膜检测方法及细菌定植的系统评价
Microorganisms. 2024 Sep 28;12(10):1966. doi: 10.3390/microorganisms12101966.
4
Prevalence of Infections and Antimicrobial Resistance of ESKAPE Group Bacteria Isolated from Patients Admitted to the Intensive Care Unit of a County Emergency Hospital in Romania.从罗马尼亚一家县急救医院重症监护病房收治的患者中分离出的ESKAPE组细菌的感染患病率及抗菌药物耐药性
Antibiotics (Basel). 2024 Apr 27;13(5):400. doi: 10.3390/antibiotics13050400.
抗生素压力下高毒力耐碳青霉烯类 ST11 的宿主体内抗性与毒力进化
Infect Drug Resist. 2023 Nov 16;16:7255-7270. doi: 10.2147/IDR.S436128. eCollection 2023.
4
A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units.一项基于欧洲药物警戒数据库报告的关于抗生素相关感染风险的药物警戒研究:对重症监护病房中一些最常用抗生素的分析。
Pharmaceuticals (Basel). 2023 Nov 9;16(11):1585. doi: 10.3390/ph16111585.
5
How biofilm changes our understanding of cleaning and disinfection.生物膜如何改变我们对清洁和消毒的理解。
Antimicrob Resist Infect Control. 2023 Sep 7;12(1):95. doi: 10.1186/s13756-023-01290-4.
6
Evaluation of the Ability to Form Biofilms in KPC-Producing and ESBL-Producing Isolated from Clinical Samples.从临床样本中分离出的产KPC和产ESBL菌株形成生物膜能力的评估。
Antibiotics (Basel). 2023 Jul 2;12(7):1143. doi: 10.3390/antibiotics12071143.
7
A Study on the Contributions of Sonication to the Identification of Bacteria Associated with Intubation Cannula Biofilm and the Risk of Ventilator-Associated Pneumonia.超声处理在鉴定与插管生物膜相关的细菌以及呼吸机相关性肺炎风险中的作用研究。
Medicina (Kaunas). 2023 May 31;59(6):1058. doi: 10.3390/medicina59061058.
8
Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance.美罗培南-法硼巴坦持续输注治疗伴有增强肾清除率的危重症伴产 KPC-3 肺炎克雷伯菌血流感染
Infection. 2023 Dec;51(6):1835-1840. doi: 10.1007/s15010-023-02055-2. Epub 2023 Jun 6.
9
Klebsiella pneumoniae survives on surfaces as a dry biofilm.肺炎克雷伯菌以干燥生物膜的形式在表面存活。
Am J Infect Control. 2023 Oct;51(10):1157-1162. doi: 10.1016/j.ajic.2023.02.009. Epub 2023 Mar 11.
10
Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.从 COVID-19 患者呼吸机相关性肺炎(VAP)感染中分离的产碳青霉烯酶肺炎克雷伯菌(CRKP)中分离、鉴定、治疗效力及新型噬菌体 vB_KshKPC-M 的基因组分析。
Ann Clin Microbiol Antimicrob. 2023 Feb 24;22(1):18. doi: 10.1186/s12941-023-00567-1.